A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants with Systemic Lupus Erythematosus

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502632-39-00

Acronym

BP44315

Enrollment

Registered

2023-08-31

Start date

2023-10-11

Completion date

Unknown

Last updated

2026-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Lupus Erythematosus (SLE)

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany, Netherlands, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026